home / stock / guerf / guerf quote
Last: | $22.25 |
---|---|
Change Percent: | 0.0% |
Open: | $22.25 |
Close: | $22.25 |
High: | $22.25 |
Low: | $22.25 |
Volume: | 200 |
Last Trade Date Time: | 07/05/2022 04:36:56 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$22.25 | $22.25 | $22.25 | $22.25 | $22.25 | 200 | 07-05-2022 |
$ | $N/A | $58.35 | $N/A | $N/A | 0 | 02-12-2020 |
$ | $N/A | $58.35 | $N/A | $N/A | 0 | 02-11-2020 |
$ | $N/A | $58.35 | $N/A | $N/A | 0 | 02-10-2020 |
$ | $N/A | $58.35 | $N/A | $N/A | 0 | 02-07-2020 |
$ | $N/A | $58.35 | $N/A | $N/A | 0 | 02-06-2020 |
$ | $N/A | $58.35 | $N/A | $N/A | 0 | 02-05-2020 |
$ | $N/A | $58.35 | $N/A | $N/A | 0 | 02-04-2020 |
$ | $N/A | $58.35 | $N/A | $N/A | 0 | 02-03-2020 |
$ | $N/A | $58.35 | $N/A | $N/A | 0 | 01-31-2020 |
$ | $N/A | $58.35 | $N/A | $N/A | 0 | 01-30-2020 |
$ | $N/A | $58.35 | $N/A | $N/A | 0 | 01-29-2020 |
$ | $N/A | $58.35 | $N/A | $N/A | 0 | 01-28-2020 |
$ | $N/A | $58.35 | $N/A | $N/A | 0 | 01-27-2020 |
$ | $N/A | $58.35 | $N/A | $N/A | 0 | 01-24-2020 |
$ | $N/A | $58.35 | $N/A | $N/A | 0 | 01-23-2020 |
$ | $N/A | $58.35 | $N/A | $N/A | 0 | 01-22-2020 |
$ | $N/A | $58.35 | $N/A | $N/A | 0 | 01-21-2020 |
$ | $N/A | $58.35 | $N/A | $N/A | 0 | 01-20-2020 |
$ | $N/A | $58.35 | $N/A | $N/A | 0 | 01-17-2020 |
News, Short Squeeze, Breakout and More Instantly...
Guerbet SA Company Name:
GUERF Stock Symbol:
OTCMKTS Market:
The CHMP issues an opinion in favour of granting an EU marketing authorisation for Elucirem™ (Gadopiclenol) with the indication of use for magnetic resonance imaging with contrast enhancement in adults and children aged 2 years and over If approved by the European...
Half-year results 2023 Acceleration of activity Half-year revenue: €378.6 million, up 2.8% at CER 1 Strong acceleration of activity in the second quarter, up 6.7% at CER Profitability in line with expectations EBITDA for the first...
First-half 2023 revenue Acceleration of activity Half-year revenue: €378.6 million, up +2.8% at CER 1 , with a strong acceleration of activity in Q2, at +6.7% Very dynamic sales in Asia (+16.6% in H1 at CER) and EMEA (+7.8%), but down in the Americas (-15...